Published in the journal Kidney International, the study includes an analysis of EHRs for 5,449 hospitalized COVID-19 patients at 13 hospitals in New York, between March 1 and April 5.
Researchers found 1,993 patients (36.6 percent) developed acute kidney injury, a sudden episode of kidney failure or damage. At the end of the study period, 39.1 percent of the 1,993 COVID-19 patients with acute kidney injury were still in the hospital, and 35 percent had died.
Acute kidney injury was primarily seen in COVID-19 patients with respiratory failure — about 89 percent of patients on mechanical ventilation developed acute kidney injury compared to 21.7% of nonventilated patients.
More articles on patient safety & outcomes:
COVID-19 nearly triples death risk of cancer patients, study finds
6 insights into COVID-19 patient care patterns worldwide
COVID-19 is 13 times deadlier than flu, study suggests
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
